These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15301465)

  • 41. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.
    Pereira GA; Stefani MM; Martelli CM; Turchi MD; Siqueira EM; Carneiro MA; Martins RM
    J Med Virol; 2006 Jun; 78(6):719-23. PubMed ID: 16628586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
    Meky FA; Stoszek SK; Abdel-Hamid M; Selim S; Abdel-Wahab A; Mikhail N; El-Kafrawy S; El-Daly M; Abdel-Aziz F; Sharaf S; Mohamed MK; Engle RE; Emerson SU; Purcell RH; Fix AD; Strickland GT
    Clin Infect Dis; 2006 Mar; 42(5):628-33. PubMed ID: 16447107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
    Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
    J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
    Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
    Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol.
    Schuval S; Van Dyke RB; Lindsey JC; Palumbo P; Mofenson LM; Oleske JM; Cervia J; Kovacs A; Dankner WN; Smith E; Nowak B; Ciupak G; Webb N; Eagle M; Smith D; Hennessey R; Goodman-Kerkau M; Levin MJ;
    Arch Pediatr Adolesc Med; 2004 Oct; 158(10):1007-13. PubMed ID: 15466691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
    Pirillo MF; Bassani L; Germinario EA; Mancini MG; Vyankandondera J; Okong P; Vella S; Giuliano M
    J Med Virol; 2007 Dec; 79(12):1797-801. PubMed ID: 17935164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
    Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of free hepatitis C virus core antigen by enzyme-linked immunosorbent assay is not suitable for screening of granulocyte colony-stimulating factor-mobilized hematopoietic progenitor donors.
    Lozano ML; Candela MJ; Cano H; Zuazu I; Vicente V
    Transfusion; 2004 Dec; 44(12):1755-61. PubMed ID: 15584991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reducing the cost of HIV-testing through use of the IgG antibody captured particle adherence test (GACPAT) in district hospitals.
    Klokke AH; Berege ZA
    Trop Geogr Med; 1995; 47(6):296-9. PubMed ID: 8650744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper.
    Pappaioanou M; Kashamuka M; Behets F; Mbala S; Biyela K; Davachi F; George JR; Green TA; Dondero TJ; Heyward WL
    AIDS; 1993 Apr; 7(4):483-8. PubMed ID: 8507414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Particle agglutination test "Serodia HIV-1/2" as a novel anti-HIV-1/2 screening test: comparative study on 3311 serum samples.
    Poljak M; Zener N; Seme K; Kristancic L
    Folia Biol (Praha); 1997; 43(4):171-3. PubMed ID: 9338125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.